Skip to main content
Premium Trial:

Request an Annual Quote

Testing the System

Britain's National Health Service aims to "test whether an entire health-care system is ready" for the personalized selection of cancer treatments via broad genetic testing, Nature News reports. "In its first phase, the program will be rolled out to as many as 12,000 NHS cancer patients over two years, beginning in early 2011," according to Nature. Breast, colorectal, prostate, and ovarian cancer patients being treated at six NHS hospitals will be screened for "several dozen mutations in about a dozen" cancer-related genes, the report adds. Fabrice André of the Gustave Roussy Institute in Villejuif, France, tells Nature that the NHS program could "really change the landscape of how molecular testing is being done for cancer. ... If they succeed, then it's going to be a major step forward."

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.